[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353505-105":59,"doc-detail-353505-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","trajectories-and-risk-factors-for-long-term-breast-symptoms-following-breast-conserving-surgery-and-radiotherapy-a-single-centre-analysis","Trajectories and risk factors for long-term breast symptoms following breast-conserving surgery and radiotherapy: a single centre analysis","","Long-term breast symptoms—pain, sensitivity, swelling, and skin problems—after breast cancer treatment can reduce survivors' quality-of-life, yet their symptom trajectories and associated risk factors remain insufficiently defined. This single-centre analysis evaluated outcomes after breast-conserving surgery and adjuvant radiotherapy (± chemotherapy), assessing breast-symptom questionnaires at multiple timepoints up to 24 months and linking persistent symptoms to psychometric measures of pain perception and anxiety.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/trajectories-and-risk-factors-for-long-term-breast-symptoms-following-breast-conserving-surgery-and-radiotherapy-a-single-centre-analysis/353505/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/trajectories-and-risk-factors-for-long-term-breast-symptoms-following-breast-conserving-surgery-and-radiotherapy-a-single-centre-analysis/353505.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of this study?","Question",{"text":112,"@type":113},"To clarify the trajectory of long-term breast symptoms after treatment and identify risk factors linked to their development and persistence.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were participants assessed over time?",{"text":117,"@type":113},"Patients completed EORTC-QLQ-BR23 breast-symptom items at four timepoints up to 24 months, and a subset later completed additional psychometric questionnaires including HADS.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were associated with more severe long-term breast symptoms?",{"text":121,"@type":113},"Higher baseline symptom scores persisted alongside smoking, any baseline analgesic use, and post-operative haematoseroma; older age and IMRT were protective in multivariable models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353505,1790355592,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Supportive Care in Cancer (2026) 34:78  \n[https://doi.org/10.1007/s00520-025-10276-4](https://doi.org/10.1007/s00520-025-10276-4)  \nTrajectories and risk factors for long‑term breast symptoms following breast‑conserving surgery and radiotherapy: a single centre analysis  \nCatherine Jones1 · Nur Nurmahomed2 · Monika Kaushik2 · Jaroslaw Krupa2 · Kelly V. Lambert2 · Simon M. Pilgrim2 · Kiran Kancherla3 · Kufre Sampson3 · Walid Sasi2 · Petra Seibold4 · R. Paul Symonds1 · Kalliope Valassiadou2 ·  \nAdam J. Webb5 · Catharine West6 · Christopher J. Talbot5 · Tim Rattay1,2  \nReceived: 14 July 2025 / Accepted: 15 December 2025 / Published online: 9 January 2026 © The Author(s) 2026  \nAbstract  \nPurpose Long-term breast symptoms (pain, sensitivity, swelling and skin problems) after breast cancer treatment can affect survivors' quality-of-life. The trajectory of breast symptoms over time and risk factors associated with their development are not well understood.  \nMethods This study built on the work of the international prospective REQUITE cohort study. Patients who underwent breast-conserving surgery and adjuvant radiotherapy (± chemotherapy) completed the EORTC-QLQ-BR23 questionnaire items relating to breast symptoms at four timepoints up to 24 months following radiotherapy. Patients at were re-contacted to complete additional psychometric questionnaires on different aspects of pain perception and the Hospital Anxiety & Depression Scale (HADS), with 237 respondents.  \nResults Average breast symptoms peaked on completion of radiotherapy but returned to levels equal to or below baseline by 24 months. Patients with more severe breast symptoms at baseline continued to have worse symptoms long-term. In multivariable mixed models, higher breast symptom scores were associated with smoking (p = 0.036), any analgesic use at baseline (p = 0.005), and post-operative haematoseroma (p = 0.034), while older age and use of intensity modulated radiotherapy (IMRT) were protective (p = \u003C 0.001 and p = 0.045 respectively) . Psychometric questionnaire scores for life interference and pain severity perception were associated with persistently increased breast symptoms at 24 months on multivariable analysis, while anxiety (as determined by HADS) was associated on univariable analysis.  \nConclusions and implications for cancer survivors This study identifies several risk factors for persistent breast symptoms including younger age, smoking, and post-operative haematoseroma. This particularly highlights the importance of smoking cessation and use of IMRT in women at higher risk of side effects.  \nKeywords Breast cancer survivorship · Quality of life · Radiotherapy side-effects · Breast pain · Multivariate analysis  \n*  \n1  \n2  \n3  \nTim Rattay [tr104@le.ac.uk](tr104@le.ac.uk)  \nLeicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester, Leicester Royal Infirmary, Leicester LE1 5WW, UK  \nDepartment of Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK  \nDepartment of Oncology, University Hospitals of Leicester NHS Trust, Leicester, UK  \n4 Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany  \n5 Department of Genetics and Genome Biology, University of Leicester, Leicester, UK  \n6 Division of Cancer Sciences, University of Manchester, Manchester, UK  \nIntroduction  \nBreast cancer remains the most common cancer in women worldwide and accounts for 15% of all new cancer cases in the UK [1] . Breast cancer survival has improved markedly, with current 10-year survival rates in the UK around 80% . In 2020, it was estimated that 600,000 women who had previously been diagnosed with breast cancer were still alive in the UK, with this number predicted to reach 1.2 million by 2030 [2] . As this community of cancer survivors continues to grow, it is important that research addresses issues relevant to their survivorship and quality of life [3] .  \nOwing to earlier cancer d","cbCailhjnjizi7St","https://ap.wps.com/l/cbCailhjnjizi7St","pdf",890851,11,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusions and implications for cancer survivors\n# Introduction","[{\"question\":\"What was the purpose of this study?\",\"answer\":\"To clarify the trajectory of long-term breast symptoms after treatment and identify risk factors linked to their development and persistence.\"},{\"question\":\"How were participants assessed over time?\",\"answer\":\"Patients completed EORTC-QLQ-BR23 breast-symptom items at four timepoints up to 24 months, and a subset later completed additional psychometric questionnaires including HADS.\"},{\"question\":\"Which factors were associated with more severe long-term breast symptoms?\",\"answer\":\"Higher baseline symptom scores persisted alongside smoking, any baseline analgesic use, and post-operative haematoseroma; older age and IMRT were protective in multivariable models.\"}]","Trajectories and risk factors for long-term breast symptoms following breast-conserving surgery and radiotherapy: a single centre analysis | PDF",1790105842,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8037e11fc17fe64f4c1511b2141b896e.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0f3a3fe0b3a3fa9dd3b662d668513f3.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9fd1e956d62e1f328f77cb17fe08d8db.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71284e7cd55c3001571fe77cedaeb331.webp",980,1301]